SCHEMBL21031255

SCHEMBL21031255

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4c5ccccc5nc5oc6ccccc6c45)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 4/20 0.37
▸ ABCG2 Q9UNQ0 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CYP1A2 P05177 4/20 0.36
▸ CYP3A4 P08684 4/20 0.36
▸ CYP2C9 P11712 4/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CLK4 Q9HAZ1 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CCNE2 O96020 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23846045 0.99 PDE5A (0.36) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21031475 0.97 PLA2G2A (0.36) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21031469 0.97 MEN1 (0.38) PDE5AABCG2MEN1KMT2AATM
SCHEMBL25847656 0.97 MEN1 (0.38) PDE5AABCG2MEN1KMT2AATM
SCHEMBL25847821 0.96 PLA2G2A (0.39) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21030669 0.96 PLA2G2A (0.39) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21031306 0.96 PLA2G2A (0.39) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21030668 0.94 PLA2G2A (0.39) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21030666 0.92 PLA2G2A (0.36) PDE5AABCG2MEN1KMT2AATM
SCHEMBL21031305 0.91 LMNA (0.40) MEN1KMT2ACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 PDE5A 3192/4885ABCG2 114/4885MEN1 3802/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 PDE5A 3192/4885ABCG2 114/4885MEN1 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback